Kidney transplantation during the COVID-19 pandemic: Potential long-term consequences of an early post-transplant infection.
Arnaud Del BelloOlivier MarionFederico SallustoAudrey DelasLaure EspositoNicolas DoumercNassim KamarPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Recently, Akalin et al.1 reported a 28% mortality among kidney-transplant patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Two of the 10 patients who died had been transplanted within the previous 5 weeks. During the coronavirus disease (COVID)-19 outbreak, kidney transplant programs were suspended in several countries2 . Although the pandemic is still ongoing, the stop of lockdown has prompted several transplant centers to restart kidney transplantation programs. It is recommended to consider that donors and recipients are screened for SARS-CoV-2 before transplantation by means of nuclear acid tests with or without chest CT scans.
Keyphrases
- kidney transplantation
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- end stage renal disease
- computed tomography
- public health
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- magnetic resonance imaging
- prognostic factors
- dual energy
- contrast enhanced
- type diabetes
- cardiovascular disease
- magnetic resonance
- risk assessment
- cell therapy
- risk factors
- mesenchymal stem cells
- bone marrow
- coronary artery disease
- human health
- patient reported